APDN Announces Fourth Quarter Fiscal Year 2023 Financial Results
February 8th, 2024
All Categories
APDN in the News
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
Press Release
Uncategorized
Vaccines
Category: Investors
APDN to Report FQ1’2024 Financial Results on Thursday, February 8, 2024
February 5th, 2024
APDN Announces Fourth Quarter Fiscal Year 2023 Financial Results
December 7th, 2023
APDN to Report FQ4’23 and Year End Financial Results 12/7/23
December 5th, 2023
Applied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate Update
May 11th, 2023
APDN Schedules FY2’21 Financial Results Conference Call and Webcast for Thursday, May 13, 2021
May 7th, 2021
Applied DNA Sciences Announces Record Date for Annual Stockholders’ Meeting
April 3rd, 2015
Applied DNA Sciences Prices $11.46 Million Public Offering
March 27th, 2015
Applied DNA Sciences Announces Proposed Public Offering
March 26th, 2015
